Have a personal or library account? Click to login
By:
Paid access
|Mar 2020

References

  1. Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science, 2002.10.1002/9780470987018
  2. Mourant AE. A ‘new’ human blood group antigen of frequent occurrence. Nature 1946;158:237–8.10.1038/158237c0
  3. Andresen PH. The blood group system L: a new blood group L2. A case of epistasy within the blood groups. Acta Path Microbiol Scand 1948;25:728–31.10.1111/j.1699-0463.1948.tb00714.x
  4. Brendemoen OJ. Further studies of agglutination and inhibition in the Lea-Leb system. J Lab Clin Med 1950;36:335–41.
  5. Ceppellini R, Dunn LC, Filomena I. Immunogenetica II. Analisi genetica formale de caratteri Lewis con particolare riguardo alla natura epistatica della specificita serologica Leb. Fol Hered Path 1959;8:261–96.
  6. Grubb R. Correlation between Lewis blood group and secretor character in man. Nature 1948;162:933.10.1038/162933a0
  7. Sanger R, Race RR. The Lutheran-secretor linkage in man: support for Mohr’s findings. Heredity 1958;12:513–20.10.1038/hdy.1958.51
  8. Grubb R, Morgan WTJ. The “Lewis” blood group characters of erythrocytes and body fluids. Br J Exp Pathol 1949;30:198–208.
  9. Grubb R. Some aspects of the complexity of the blood groups ABO. Rev Hematol 1950;5:268–75.
  10. Grubb R. Observations on the human group system Lewis. Acta Path Microbiol Scand 1951;28:61–81.10.1111/j.1699-0463.1951.tb05004.x
  11. Brendemoen OJ. Studies of agglutination and inhibition in two Lewis antibodies. J Lab Clin Med 1949;34:538–42.
  12. Sneath JS, Sneath PHA. Transformation of the Lewis groups of human red cells. Nature 1955;176:172.10.1038/176172a0
  13. Mollison PL, Polley MJ, Crome P. Temporary suppression of Lewis blood-group antibodies to permit incompatible transfusion. Lancet 1963;1:909–12.10.1016/S0140-6736(63)91689-1
  14. Marcus DM, Cass LE. Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science 1969;164:553–5.10.1126/science.164.3879.5535778002
  15. Watkins WM. A half century of blood-group antigen research: some personal recollections. Trends Glycosci Glycotechnol 1999;11:391–411.10.4052/tigg.11.391
  16. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.10.1016/B978-012586585-2/50007-X
  17. Henry SM, Benny AG, Woodfield DG. Investigation of Lewis phenotypes in Polynesians: evidence of a weak secretor phenotype. Vox Sang 1990;58:61–6.10.1111/j.1423-0410.1990.tb02057.x2316213
  18. Rouquier S, Lowe JB, Kelly RJ, et al. Molecular cloning of a human genomic region containing the H blood group a(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments: isolation of a candidate gene for the human Secretor blood group locus. J Biol Chem 1995;270:4632–9.10.1074/jbc.270.9.46327876234
  19. Kelly RJ, Rouquier S, Giorgi D, et al. Sequence and expression of a candidate for the human secretor blood a(1,2)-fucosyltransferase gene (FUT2). J Biol Chem 1995;270:4640–9.10.1074/jbc.270.9.46407876235
  20. Reguigne-Arnould I, Couillin P, Mollicone R, et al. Relative positions of two clusters of human a-Lfucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenet Cell Gen 1995;71:158–62.10.1159/0001340987656588
  21. Koda Y, Soejima M, Kimura H. Structure and expression of the gene encoding secretor-type galactoside 2-a-L-fucosyltransferase (FUT2). Eur J Biochem 1997;246:750–5.10.1111/j.1432-1033.1997.t01-1-00750.x9219535
  22. Soejima M, Koda Y. Molecular mechanisms of Lewis antigen expression. Leg Med (Tokyo) 2005;7:266–9.10.1016/j.legalmed.2004.12.00315946883
  23. Henry S, Mollicone R, Fernandez P, et al. Molecular basis for erythrocyte Le(a+b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A→T mutation at nucleotide 385 correlates with reduced alpha(1,2) fucosyltransferase activity. Glycoconj J 1996;13:985–93.10.1007/BF010531948981090
  24. Koda Y, Soejima M, Johnson PH, et al. Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay Phenotype of ABO blood group system. Biochem Biophys Res Commun 1997;238:21–5.10.1006/bbrc.1997.72329299444
  25. Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group a(1,3/1,4)fucosyltransferase. Genes Dev 1990;4:1288–303.10.1101/gad.4.8.12881977660
  26. Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8–16.10.1002/humu.10296
  27. Watkins WM. Blood-group substances. Science 1966;152:172–81.10.1126/science.152.3719.172
  28. Kobata A, Grollman EF, Ginsberg V. An enzymatic basis for blood type A in humans. Arch Biochem Biophys 1968;124:609–12.10.1016/0003-9861(68)90373-1
  29. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
  30. Clausen H, Levery SB, McKibbon JM, Hakomori S. Blood group A determinants with mono- and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry 1985;24:3578–86.10.1021/bi00335a028
  31. Breimer ME, Karlsson K-A, Samuelsson BE. Characterization of a human intestinal difucosyl heptaglycosylceramide with a blood group B determinant and a type 1 carbohydrate chain. J Biol Chem 1982;257:1079–85.10.1016/S0021-9258(19)68310-9
  32. Schenkel-Brunner H. Human blood groups: chemical and biochemical basis of antigen specificity. 2nd ed. New York: Springer-Verlag, 2000.10.1007/978-3-7091-6294-1
  33. Cutbush M, Giblett ER, Mollison PL. Demonstration of the phenotype Le(a+b+) in infants and in adults. Br J Haematol 1956;2:210–20.10.1111/j.1365-2141.1956.tb06829.x13315907
  34. Lin M, Shieh SH. Postnatal development of red cell Lea and Leb antigens in Chinese infants. Vox Sang 1994;66:137–40.
  35. Lawler SD, Marshall R. Lewis and Secretor characters in infancy. Vox Sang 1961;6:541–4.
  36. Oriol R. ABO, Hh, Lewis and secretions: serology, genetics and tissue distribution. In: Cartron JP, Rouger P, eds. Blood cell biochemistry: molecular basis of major blood group antigens. New York: Plenum, 1994:37–73.
  37. Kissmeyer-Nielsen F. Irregular blood group antibodies in 200,000 individuals. Scand J Haematol 1965;2:331–42.10.1111/j.1600-0609.1965.tb01309.x4956224
  38. Brendemoen OJ. Some factors influencing Rh immunization during pregnancy. Acta Path Microbiol Scand 1952;31:579–83.10.1111/j.1699-0463.1952.tb00225.x
  39. Hammar L, Mansson S, Rohr T, et al. Lewis phenotype of erythrocytes and Leb-active glycolipid in serum of pregnant women. Vox Sang 1981;40:27–33.10.1111/j.1423-0410.1981.tb00665.x7222561
  40. Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS 2000;108:1–28.10.1034/j.1600-0463.2000.d01-1.x
  41. Watkins WM, Morgan WT. Specific inhibition studies relating to the Lewis blood-group system. Nature 1957;180:1038–40.10.1038/1801038a0
  42. McConnell RB. Lewis blood group substances in body fluids. Istituto GM (ed.) Proc 2nd Congr Hum Genet, Rome, Italy 1961:858–61.
  43. Morgan WT. A contribution to human biochemical genetics; the chemical basis of blood-group specificity. Proc R Soc Lond B Biol Sci 1960;151:308–47.10.1098/rspb.1960.0002
  44. Arcilla MB, Sturgeon P. Lewis and ABH substances in amniotic fluid obtained by amniocentesis. Pediatr Res 1972;6:853–8.10.1203/00006450-197212000-00001
  45. Dunstan RA, Simpson MB, Rosse WF. Lea blood group antigen on human platelets. Am J Clin Pathol 1985;83:90–4.10.1093/ajcp/83.1.90
  46. Hanfland P, Graham HA. Immunochemistry of the Lewis-blood-group systems: partial characterization of Lea-, Leb-, and H-Type 1(LedH)-blood-group active glycosphingolipids from human plasma. Arch Biochem Biophys 1981;210:383–95.10.1016/0003-9861(81)90201-0
  47. Ramsey G, Fryer JP, Teruya J, Sherman LA. Lewis (a-b-) red cell phenotype in patients undergoing evaluation for small intestinal transplantation. (abstract) Transfusion 2000;40(Suppl):114S.10.1046/j.1537-2995.2000.40020253.x10686012
  48. Oriol R, Le Pendu J, Sparkes RS, et al. Insights into the expression of ABH and Lewis antigens through human bone marrow transplantation. Am J Hum Genet 1981;33:551–60.
  49. Oriol R, Cartron JP, Cartron J, Mulet C. Biosynthesis of ABH and Lewis antigens in normal and transplanted kidneys. Transplantation 1980;29:184–8.10.1097/00007890-198003000-000036987782
  50. Dzik WH, Mondor LA, Maillet SM, Jenkins RL. ABO and Lewis blood group antigens of donor origin in the bile of patients after liver transplantation. Transfusion 1987;27:384–7.10.1046/j.1537-2995.1987.27587320528.x3307037
  51. Miller EB, Rosenfield RE, Vogel P, et al. The Lewis blood factors in American Negroes. Am J Phys Anthropol 1954;12:427–43.10.1002/ajpa.133012031613207336
  52. Garratty G, Kleinschmidt G. Two examples of anti-Leb detected in the sera of patients with the Lewis phenotype Le(a+b-). Vox Sang 1965;10:567–71.
  53. Kornstad L. Anti-Leb in the serum of Le(a+b-) and Le(a-b-) persons: absorptions studies with erythrocytes of different ABO and Lewis phenotypes. Vox Sang 1969;16:124–9.
  54. Spitalnik S, Cowles J, Cox MT, et al. A new technique in quantitative immunohematology: solid-phase kinetic ELISA. Vox Sang 1983;45:440–8.10.1111/j.1423-0410.1983.tb01942.x6362193
  55. Spitalnik S, Cowles J, Cox MT, Blumberg N. Detection of IgG anti-Lewisa antibodies in cord sera by kinetic ELISA. Vox Sang 1985;48:235–8.10.1111/j.1423-0410.1985.tb00177.x3984308
  56. Molthan L, Strohm PL, Gross BM, Paradis DJ. Frequencies and immunoglobulin classes of the Lewis, P1, and MN system antibodies. Lab Med 1983;14:422–6.10.1093/labmed/14.7.422
  57. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Science, 1997.
  58. Cheng MS, Lukomskyi L. Lewis antibody following a massive blood transfusion. Vox Sang 1989;57:155–6.10.1111/j.1423-0410.1989.tb01156.x2781743
  59. Hossaini AA. Neutralization of Lewis antibodies in vivo and transfusion of Lewis incompatible blood. Am J Clin Pathol 1972;57:489–93.10.1093/ajcp/57.4.4895012942
  60. Holburn AM. Quantitative studies with (125I) IgM anti-Lea. Immunology 1973;24:1019–26.
  61. de Vries SI, Smitskamp HS. Haemolytic transfusion reactions due to anti-Lewisa agglutinin. Br Med J 1951;1:280–1.10.1136/bmj.1.4701.280206830814821388
  62. Brendemoen OJ, Aas K. Hemolytic transfusion reaction probably caused by anti-Lea. Acta Med Scand 1952;141:458–60.
  63. Roy RB, Wesley RH, Fitzgerald JD. Haemolytic transfusion reaction caused by anti-Lea. Vox Sang 1960;5:546–50.10.1111/j.1423-0410.1960.tb04041.x13744205
  64. Mollison PL, Cutbush M. Use of isotope-labeled red cells to demonstrate incompatibility in vivo. Lancet 1955;268:1290–5.
  65. Quiroga H, Leite A, Baia F, et al. Clinically significant anti-Leb.(abstract) Vox Sang 2000;78(Suppl 1):P125.
  66. Jesse JK, Sheek KJ. Anti-Leb implicated in acute hemolytic transfusion reaction: a rare occurrence. (abstract) Transfusion 2000;40(Suppl):115S.
  67. Pineda AA, Taswel HG, Brzica SM. Delayed hemolytic transfusion reaction. An immunological hazard of blood transfusion. Transfusion 1978;18:1–7.10.1046/j.1537-2995.1978.18178118550.x415392
  68. Weir AB, Woods LL, Chesney C, Neitzer G. Delayed hemolytic transfusion reaction caused by anti-LebH antibody. Vox Sang 1987;53:105–7.10.1111/j.1423-0410.1987.tb04928.x3120409
  69. Contreras M, Mollison PL. Delayed haemolytic transfusion reactions caused by anti-LebH. Vox Sang 1989;56:290.
  70. Waheed A, Kennedy MS, Gerhan S, Senhauser DA. Transfusion significance of Lewis system antibodies. Am J Clin Pathol 1981;76:294–8.10.1093/ajcp/76.3.2947282630
  71. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.10.1016/j.tmrv.2006.08.003
  72. Carreras Vescio LA, Torres OW, Virgilio OS, Pizzolato M. Mild hemolytic disease of newborn due to anti-Lewisa. Vox Sang 1993;64:194–5.10.1159/000462347
  73. Bharucha ZS, Joshi SR, Bhatia HM. Hemolytic disease of the newborn due to anti-Leb. Vox Sang 1981;41:36–9.10.1111/j.1423-0410.1981.tb01009.x
  74. Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892–5.10.1126/science.8018146
  75. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997;349:265–9.10.1016/S0140-6736(96)07023-7
  76. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 2004;9:342–6.10.1111/j.1083-4389.2004.00238.x15270749
  77. Hutson AM, Atmar RL, Marcus DM, Estes MK. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J Virol 2003;77:405–15.10.1128/JVI.77.1.405-415.200314060212477845
  78. Hilton E, Chandrasekaran V, Rindos P, Isenberg HD. Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. J Infect Dis 1995;172:1616–19.10.1093/infdis/172.6.16167594730
  79. Stapleton A, Nudelman E, Clausen H, et al. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992;90:965–72.10.1172/JCI1159733299521522244
  80. Hein HO, Sorensen H, Suadicani P, et al. The Lewis blood group—a new genetic marker of ischaemic heart disease. J Intern Med 1992;232:481–7.10.1111/j.1365-2796.1992.tb00620.x1474347
  81. Clausen JO, Hein HO, Suadicdani P, et al. Lewis phenotypes and the insulin resistance syndrome in young healthy white men and women. Am J Hypertens 1995;8:1060–6.10.1016/0895-7061(95)00247-M
  82. Hein HO, Suadicani P, Gyntelberg F. The Lewis blood group—a new genetic marker of obesity. Int J Obes (Lond) 2005;29:540–2.10.1038/sj.ijo.0802923
  83. Hirschberg CB. Golgi nucleotide sugar transport and leukocyte adhesion deficiency II. J Clin Invest 2001;108:3–6.10.1172/JCI200113480
  84. Luhn K, Wild MK, Eckhardt M, et al. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet 2001;28:69–72.10.1038/ng0501-69
  85. Oriol R, Opelz G, Chun C, Terasaki PI. The Lewis system and kidney transplantation. Transplantation 1980;29:397–400.10.1097/00007890-198005000-00010
  86. Oriol R, Cartron J-P, Yvart J, et al. The Lewis system: new histocompatibility antigens in renal transplantation. Lancet 1978;1:574–5.10.1016/S0140-6736(78)91024-3
  87. Salmon C, Cartron J-P, Rouger P. The human blood groups. New York: Masson, 1984.
  88. Fischer E, Lenhard V, Romer W, et al. Influence of Lewis blood group system on clinical kidney transplantation. Proc Eur Dial Transplant Assoc 1979;16:377–82.
  89. Posner MP, McGeorge MB, Mendez-Picon G, et al. The importance of the Lewis system in cadaver renal transplantation. Transplantation 1986;41:474–7.10.1097/00007890-198604000-00012
  90. Gratama JW, Hendriks GF, Persijn GG, et al. The interaction between Lewis blood group system and HLA-matching in renal transplantation. Transplantation.1988;45:926–9.10.1097/00007890-198805000-00017
  91. Williams G, Pegrum GD, Evans CA. Lewis antigens in renal transplantation. Lancet 1978;1:878.10.1016/S0140-6736(78)90222-2
  92. Spitalnik S, Pfaff W, Cowles J, et al. Correlation of humoral immunity to Lewis blood group antigens with renal transplantation rejection. Transplantation 1984:37:265–8.10.1097/00007890-198403000-000106367166
  93. Boratynska M, Banasik M, Halon A, et al. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients. Transplant Proc 2007;39:2711–14.10.1016/j.transproceed.2007.08.05318021965
DOI: https://doi.org/10.21307/immunohematology-2019-243 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 112 - 118
Published on: Mar 20, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 M.R. Combs, published by American National Red Cross
This work is licensed under the Creative Commons License.